Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

More Physicians, Patients Using Telehealth To Save Costs, Improve Care

Executive Summary

Medical and community care experts briefing senators this week touted telehealth as a viable methodology to control health-care costs and improve patient outcomes.

You may also be interested in...



CMS Releases Telehealth Final Rule For Medicare Advantage Patients

The rule from the US Centers for Medicare and Medicaid Services affects Medicare Advantage patients, which means many more beneficiaries will have access to telehealth services.

What's Ahead In The US Senate: Support Builds For Bills To Lower Health-Care Costs, End Device Tax

The medtech industry should expect legislation to gain attention in the US Senate in the coming months to lower health-care costs and promote transparency to allow cost-conscious patients to shop for the most effective and lowest-priced surgical and advanced imaging procedures, as well as bills to repeal the device tax, key Senate health players say.

Medtech Provisions Approved In US Budget Agreement

Medtech and funding provisions in a two-year budget deal that the US Senate and House approved early Friday morning and which were signed by the President would extend Medicate telehealth programs, remove a rental cap for speech-generating devices and strengthen competitive bidding rules to assure access to diabetic test strips, among others. 

Topics

UsernamePublicRestriction

Register

MT124614

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel